| scholarly article | Q13442814 |
| P50 | author | Nevan Krogan | Q28450952 |
| Kimberly M Sogi | Q87934461 | ||
| Sarah A Stanley | Q87934465 | ||
| P2093 | author name string | Jeffrey R Johnson | |
| Katie A Lien | |||
| P2860 | cites work | CellProfiler: image analysis software for identifying and quantifying cell phenotypes | Q24676898 |
| The lysosome: from waste bag to potential therapeutic target | Q27022248 | ||
| Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review | Q27022535 | ||
| Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis | Q27334479 | ||
| MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments | Q42658640 | ||
| Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. | Q44021327 | ||
| ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli | Q80066496 | ||
| Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen | Q28473689 | ||
| A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system | Q28486783 | ||
| Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation | Q28487528 | ||
| Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth | Q28539975 | ||
| MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
| STATs in cancer inflammation and immunity: a leading role for STAT3 | Q29547203 | ||
| Java Treeview--extensible visualization of microarray data | Q29547226 | ||
| Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages | Q29547420 | ||
| Open source clustering software | Q29547702 | ||
| HTSeq--a Python framework to work with high-throughput sequencing data | Q29614489 | ||
| Identification of nitric oxide synthase as a protective locus against tuberculosis | Q29620411 | ||
| New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics | Q30371980 | ||
| The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans | Q30495582 | ||
| Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding. | Q31031297 | ||
| Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. | Q33538366 | ||
| Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis. | Q33554130 | ||
| Autophagy: cellular and molecular mechanisms | Q34103624 | ||
| EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation | Q34282375 | ||
| The epidermal growth factor receptor family: biology driving targeted therapeutics | Q34692233 | ||
| Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function | Q34997011 | ||
| Toxoplasma gondii-induced activation of EGFR prevents autophagy protein-mediated killing of the parasite. | Q35075123 | ||
| The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells | Q35125060 | ||
| Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis | Q36038705 | ||
| Risk of tuberculosis reactivation with tofacitinib (CP-690550). | Q36153907 | ||
| The epidermal growth factor receptor family | Q36236606 | ||
| Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening. | Q36575914 | ||
| The epidermal growth factor receptor pathway: a model for targeted therapy | Q36603677 | ||
| Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics. | Q37214709 | ||
| Host-directed therapeutics for tuberculosis: can we harness the host? | Q38168037 | ||
| SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis | Q38280204 | ||
| A high content screening assay for identifying lysosomotropic compounds | Q39615924 | ||
| Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis | Q39878562 | ||
| Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy | Q40250473 | ||
| An atlas of human kinase regulation | Q40281817 | ||
| Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events | Q40311521 | ||
| HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis. | Q40609000 | ||
| STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection | Q40623428 | ||
| IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. | Q41764389 | ||
| The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells | Q41867971 | ||
| Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics | Q42013412 | ||
| Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection. | Q42524734 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 8 | |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 564-574 | |
| P577 | publication date | 2017-06-05 | |
| P1433 | published in | ACS Infectious Diseases | Q24067932 |
| P1476 | title | The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling | |
| P478 | volume | 3 |
| Q92726470 | Dynamic post-translational modification profiling of Mycobacterium tuberculosis-infected primary macrophages |
| Q54960633 | Kinase inhibitors in clinical practice: An expanding world. |
| Q90293831 | Production of β-Lactamase Inhibitors by Streptomyces Species |
| Q91474358 | Therapeutic host-directed strategies to improve outcome in tuberculosis |
| Q57299995 | Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis |
| Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |
Search more.